| 0 |
CUTANEOUS EXTRAMEDULLARY HAEMOPOIESIS |
4 |
0.6667 |
| 1 |
MYELODYSPLASTIC SYNDROME WITH MULTILINEAGE DYSPLASIA |
13 |
0.2549 |
| 2 |
IVTH NERVE PARALYSIS |
42 |
0.1772 |
| 3 |
PHALANGEAL HYPOPLASIA |
12 |
0.1690 |
| 4 |
TRANSPLANT ABSCESS |
6 |
0.1304 |
| 5 |
ENCEPHALITIS PROTOZOAL |
7 |
0.1250 |
| 6 |
HAEMOPHILUS BACTERAEMIA |
6 |
0.1224 |
| 7 |
CUTANEOUS MUCORMYCOSIS |
21 |
0.1141 |
| 8 |
MENINGOENCEPHALITIS AMOEBIC |
6 |
0.1034 |
| 9 |
CUTANEOUS MALACOPLAKIA |
5 |
0.0980 |
| 10 |
ACANTHAMOEBA INFECTION |
17 |
0.0904 |
| 11 |
HEPATIC AMOEBIASIS |
6 |
0.0896 |
| 12 |
CAMPYLOBACTER TEST POSITIVE |
6 |
0.0789 |
| 13 |
CUTANEOUS NOCARDIOSIS |
9 |
0.0692 |
| 14 |
VOCAL CORD OPERATION |
6 |
0.0638 |
| 15 |
MALACOPLAKIA |
28 |
0.0611 |
| 16 |
DISSEMINATED TOXOPLASMOSIS |
7 |
0.0583 |
| 17 |
PULMONARY NOCARDIOSIS |
46 |
0.0558 |
| 18 |
SPONTANEOUS BACTERIAL PERITONITIS |
12 |
0.0492 |
| 19 |
TOTAL LUNG CAPACITY INCREASED |
13 |
0.0478 |
| 20 |
PHARYNGEAL CYST |
5 |
0.0463 |
| 21 |
SCROTAL ULCER |
11 |
0.0421 |
| 22 |
FUNGAL DISEASE CARRIER |
4 |
0.0396 |
| 23 |
GASTROINTESTINAL TRACT MUCOSAL PIGMENTATION |
10 |
0.0368 |
| 24 |
DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION |
8 |
0.0362 |
| 25 |
NOCARDIOSIS |
92 |
0.0359 |
| 26 |
CEREBELLAR STROKE |
14 |
0.0358 |
| 27 |
CHEST WALL ABSCESS |
7 |
0.0354 |
| 28 |
SUSPECTED DRUG-INDUCED LIVER INJURY |
7 |
0.0350 |
| 29 |
MORGANELLA INFECTION |
10 |
0.0341 |
| 30 |
PENILE ULCERATION |
11 |
0.0336 |
| 31 |
DEVICE RELATED BACTERAEMIA |
10 |
0.0323 |
| 32 |
ACUTE PULMONARY HISTOPLASMOSIS |
5 |
0.0314 |
| 33 |
BURKHOLDERIA CEPACIA COMPLEX INFECTION |
8 |
0.0280 |
| 34 |
CRYPTOCOCCAL FUNGAEMIA |
4 |
0.0280 |
| 35 |
LEISHMANIASIS |
8 |
0.0276 |
| 36 |
IGA NEPHROPATHY |
45 |
0.0271 |
| 37 |
ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME |
14 |
0.0268 |
| 38 |
CONGENITAL FOOT MALFORMATION |
12 |
0.0264 |
| 39 |
CONGENITAL APLASIA |
8 |
0.0257 |
| 40 |
PNEUMOCYSTIS JIROVECII INFECTION |
25 |
0.0209 |
| 41 |
FUNGAL PHARYNGITIS |
5 |
0.0199 |
| 42 |
ENTEROCOCCAL BACTERAEMIA |
20 |
0.0189 |
| 43 |
CORNEAL INFECTION |
4 |
0.0184 |
| 44 |
PROTEUS INFECTION |
13 |
0.0181 |
| 45 |
HUMAN HERPESVIRUS 8 INFECTION |
11 |
0.0181 |
| 46 |
ANAEMIA MEGALOBLASTIC |
8 |
0.0179 |
| 47 |
DISSEMINATED MUCORMYCOSIS |
7 |
0.0178 |
| 48 |
MONOCLONAL IMMUNOGLOBULIN INCREASED |
5 |
0.0175 |
| 49 |
ARTERIOVENOUS FISTULA THROMBOSIS |
6 |
0.0173 |
| 50 |
CENTRAL NERVOUS SYSTEM FUNGAL INFECTION |
4 |
0.0172 |
| 51 |
FUSARIUM INFECTION |
12 |
0.0171 |
| 52 |
CEREBRAL TOXOPLASMOSIS |
16 |
0.0171 |
| 53 |
WOUND INFECTION BACTERIAL |
7 |
0.0169 |
| 54 |
TOXOPLASMOSIS |
18 |
0.0167 |
| 55 |
CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER |
6 |
0.0165 |
| 56 |
CHRONIC GRAFT VERSUS HOST DISEASE ORAL |
4 |
0.0163 |
| 57 |
VASOGENIC CEREBRAL OEDEMA |
11 |
0.0153 |
| 58 |
CHYLOTHORAX |
11 |
0.0153 |
| 59 |
LUNG TRANSPLANT REJECTION |
10 |
0.0152 |
| 60 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
152 |
0.0151 |
| 61 |
GRAFT VERSUS HOST DISEASE IN LUNG |
7 |
0.0146 |
| 62 |
EVANS SYNDROME |
7 |
0.0142 |
| 63 |
CEREBRAL MASS EFFECT |
5 |
0.0138 |
| 64 |
SYPHILIS |
10 |
0.0138 |
| 65 |
MIXED LIVER INJURY |
41 |
0.0136 |
| 66 |
GENERALISED BULLOUS FIXED DRUG ERUPTION |
5 |
0.0134 |
| 67 |
DISSEMINATED CRYPTOCOCCOSIS |
10 |
0.0132 |
| 68 |
ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION |
12 |
0.0130 |
| 69 |
ANAL ULCER |
10 |
0.0122 |
| 70 |
VULVAL DISORDER |
8 |
0.0121 |
| 71 |
MUCORMYCOSIS |
30 |
0.0115 |
| 72 |
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME |
57 |
0.0114 |
| 73 |
PULMONARY MUCORMYCOSIS |
6 |
0.0114 |
| 74 |
DELAYED GRAFT FUNCTION |
8 |
0.0113 |
| 75 |
JARISCH-HERXHEIMER REACTION |
8 |
0.0112 |
| 76 |
MYCOBACTERIAL INFECTION |
19 |
0.0110 |
| 77 |
ZYGOMYCOSIS |
5 |
0.0107 |
| 78 |
ENTEROCOCCAL INFECTION |
50 |
0.0103 |
| 79 |
MARROW HYPERPLASIA |
7 |
0.0103 |
| 80 |
ENTEROCOCCAL SEPSIS |
8 |
0.0099 |
| 81 |
MENINGITIS LISTERIA |
5 |
0.0098 |
| 82 |
GENE MUTATION |
19 |
0.0096 |
| 83 |
SYSTEMIC CANDIDA |
24 |
0.0096 |
| 84 |
METHAEMOGLOBINAEMIA |
22 |
0.0095 |
| 85 |
GRAFT VERSUS HOST DISEASE |
67 |
0.0093 |
| 86 |
THROMBOTIC MICROANGIOPATHY |
90 |
0.0092 |
| 87 |
LICHENOID KERATOSIS |
21 |
0.0092 |
| 88 |
STAPHYLOCOCCAL SKIN INFECTION |
11 |
0.0089 |
| 89 |
CYTOMEGALOVIRUS CHORIORETINITIS |
17 |
0.0087 |
| 90 |
HEPATIC CYTOLYSIS |
111 |
0.0087 |
| 91 |
IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME |
51 |
0.0086 |
| 92 |
PARAINFLUENZAE VIRUS INFECTION |
13 |
0.0085 |
| 93 |
INFECTIOUS PLEURAL EFFUSION |
13 |
0.0085 |
| 94 |
CYTOMEGALOVIRUS TEST POSITIVE |
15 |
0.0084 |
| 95 |
DERMO-HYPODERMITIS |
5 |
0.0084 |
| 96 |
ENTEROBACTER INFECTION |
14 |
0.0083 |
| 97 |
KLEBSIELLA INFECTION |
40 |
0.0079 |
| 98 |
VOCAL CORD PARALYSIS |
14 |
0.0078 |
| 99 |
INVASIVE LOBULAR BREAST CARCINOMA |
4 |
0.0078 |
| 100 |
MUCOSAL DISCOLOURATION |
5 |
0.0078 |
| 101 |
IMMUNE RECONSTITUTION SYNDROME |
10 |
0.0077 |
| 102 |
KLEBSIELLA TEST POSITIVE |
5 |
0.0077 |
| 103 |
CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN |
7 |
0.0076 |
| 104 |
GASTROINTESTINAL INJURY |
20 |
0.0074 |
| 105 |
PNEUMONIA FUNGAL |
29 |
0.0073 |
| 106 |
CYTOMEGALOVIRUS VIRAEMIA |
32 |
0.0072 |
| 107 |
HYPOMANIA |
26 |
0.0071 |
| 108 |
GRAFT VERSUS HOST DISEASE IN SKIN |
15 |
0.0068 |
| 109 |
STAPHYLOCOCCAL BACTERAEMIA |
29 |
0.0067 |
| 110 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
50 |
0.0067 |
| 111 |
BICYTOPENIA |
13 |
0.0066 |
| 112 |
FEBRILE BONE MARROW APLASIA |
28 |
0.0066 |
| 113 |
GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT |
14 |
0.0066 |
| 114 |
PNEUMONIA KLEBSIELLA |
12 |
0.0065 |
| 115 |
URINARY TRACT INFECTION ENTEROCOCCAL |
6 |
0.0064 |
| 116 |
HEPATOBILIARY DISEASE |
4 |
0.0064 |
| 117 |
KLEBSIELLA BACTERAEMIA |
6 |
0.0063 |
| 118 |
ASPERGILLUS INFECTION |
41 |
0.0062 |
| 119 |
GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE |
7 |
0.0062 |
| 120 |
HISTOPLASMOSIS |
11 |
0.0062 |
| 121 |
PNEUMONIA CYTOMEGALOVIRAL |
12 |
0.0062 |
| 122 |
CYTOKINE RELEASE SYNDROME |
119 |
0.0059 |
| 123 |
DEMYELINATING POLYNEUROPATHY |
6 |
0.0058 |
| 124 |
PNEUMOCYSTIS JIROVECI PNEUMONIA |
13 |
0.0058 |
| 125 |
GRANULOMATOSIS WITH POLYANGIITIS |
7 |
0.0058 |
| 126 |
VIRAEMIA |
8 |
0.0058 |
| 127 |
ANAEMIA MACROCYTIC |
12 |
0.0056 |
| 128 |
MYCOBACTERIUM AVIUM COMPLEX INFECTION |
15 |
0.0056 |
| 129 |
ESCHERICHIA BACTERAEMIA |
13 |
0.0055 |
| 130 |
LISTERIOSIS |
6 |
0.0054 |
| 131 |
JAUNDICE CHOLESTATIC |
19 |
0.0054 |
| 132 |
VASCULAR PSEUDOANEURYSM |
9 |
0.0052 |
| 133 |
AGRANULOCYTOSIS |
96 |
0.0052 |
| 134 |
IMMUNOSUPPRESSANT DRUG LEVEL INCREASED |
17 |
0.0051 |
| 135 |
IMMUNE-MEDIATED HEPATIC DISORDER |
10 |
0.0051 |
| 136 |
HISTOPLASMOSIS DISSEMINATED |
8 |
0.0050 |
| 137 |
BRONCHOPULMONARY ASPERGILLOSIS |
39 |
0.0050 |
| 138 |
PNEUMOMEDIASTINUM |
9 |
0.0050 |
| 139 |
LUNG OPACITY |
13 |
0.0049 |
| 140 |
ORAL MUCOSA EROSION |
6 |
0.0049 |
| 141 |
SPONTANEOUS HAEMORRHAGE |
5 |
0.0049 |
| 142 |
STERNAL FRACTURE |
6 |
0.0049 |
| 143 |
CORONAVIRUS TEST POSITIVE |
5 |
0.0049 |
| 144 |
ADENOVIRUS INFECTION |
14 |
0.0048 |
| 145 |
LUNG ABSCESS |
10 |
0.0048 |
| 146 |
BRAIN ABSCESS |
12 |
0.0047 |
| 147 |
STEROID DIABETES |
7 |
0.0047 |
| 148 |
ORGANISING PNEUMONIA |
23 |
0.0046 |
| 149 |
VANISHING BILE DUCT SYNDROME |
5 |
0.0045 |
| 150 |
INFECTION REACTIVATION |
5 |
0.0044 |
| 151 |
CENTRAL NERVOUS SYSTEM LYMPHOMA |
6 |
0.0044 |
| 152 |
DYSLEXIA |
5 |
0.0043 |
| 153 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
19 |
0.0043 |
| 154 |
OPTIC NEUROPATHY |
9 |
0.0042 |
| 155 |
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE |
6 |
0.0042 |
| 156 |
INTRACRANIAL MASS |
4 |
0.0042 |
| 157 |
DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY |
4 |
0.0042 |
| 158 |
BACTERAEMIA |
50 |
0.0042 |
| 159 |
VARICELLA |
10 |
0.0042 |
| 160 |
UPPER RESPIRATORY TRACT INFLAMMATION |
5 |
0.0042 |
| 161 |
TOXIC EPIDERMAL NECROLYSIS |
63 |
0.0041 |
| 162 |
CYTOPENIA |
50 |
0.0041 |
| 163 |
HAEMOPHILUS INFECTION |
4 |
0.0041 |
| 164 |
DACTYLITIS |
4 |
0.0041 |
| 165 |
ENCEPHALOPATHY |
99 |
0.0040 |
| 166 |
ESCHERICHIA INFECTION |
33 |
0.0040 |
| 167 |
PERSECUTORY DELUSION |
10 |
0.0040 |
| 168 |
MENINGITIS CRYPTOCOCCAL |
7 |
0.0040 |
| 169 |
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN |
11 |
0.0040 |
| 170 |
RASH MORBILLIFORM |
11 |
0.0040 |
| 171 |
HYPERBILIRUBINAEMIA |
41 |
0.0040 |
| 172 |
IMMUNE-MEDIATED HEPATITIS |
8 |
0.0039 |
| 173 |
CALCULUS URINARY |
6 |
0.0039 |
| 174 |
HYPERURICAEMIA |
16 |
0.0039 |
| 175 |
FUNGAEMIA |
6 |
0.0038 |
| 176 |
PNEUMONIA BACTERIAL |
35 |
0.0038 |
| 177 |
MYOPIA |
9 |
0.0038 |
| 178 |
CRYPTOCOCCOSIS |
6 |
0.0037 |
| 179 |
CYTOMEGALOVIRUS INFECTION |
60 |
0.0036 |
| 180 |
VACCINATION FAILURE |
6 |
0.0036 |
| 181 |
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS |
28 |
0.0036 |
| 182 |
BRAIN DEATH |
11 |
0.0036 |
| 183 |
PNEUMONIA STAPHYLOCOCCAL |
7 |
0.0035 |
| 184 |
ATYPICAL MYCOBACTERIAL INFECTION |
5 |
0.0035 |
| 185 |
CATAPLEXY |
5 |
0.0035 |
| 186 |
DIFFUSE LARGE B-CELL LYMPHOMA |
27 |
0.0035 |
| 187 |
CORTISOL DECREASED |
4 |
0.0035 |
| 188 |
POST HERPETIC NEURALGIA |
5 |
0.0035 |
| 189 |
TONGUE COATED |
6 |
0.0035 |
| 190 |
NOROVIRUS INFECTION |
5 |
0.0035 |
| 191 |
DERMATITIS EXFOLIATIVE GENERALISED |
12 |
0.0034 |
| 192 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
30 |
0.0034 |
| 193 |
SPLENIC INFARCTION |
6 |
0.0034 |
| 194 |
EXTREMITY NECROSIS |
6 |
0.0034 |
| 195 |
LIP ULCERATION |
4 |
0.0034 |
| 196 |
PNEUMONIA PNEUMOCOCCAL |
5 |
0.0034 |
| 197 |
RHINITIS ALLERGIC |
15 |
0.0034 |
| 198 |
EPSTEIN-BARR VIRUS INFECTION |
21 |
0.0034 |
| 199 |
PANCYTOPENIA |
186 |
0.0033 |
| 200 |
RASH MACULO-PAPULAR |
74 |
0.0033 |
| 201 |
SOFT TISSUE INFECTION |
6 |
0.0033 |
| 202 |
BRONCHIECTASIS |
22 |
0.0033 |
| 203 |
OESOPHAGEAL CANDIDIASIS |
13 |
0.0033 |
| 204 |
ACUTE MYELOID LEUKAEMIA RECURRENT |
7 |
0.0033 |
| 205 |
PNEUMONIA PSEUDOMONAL |
5 |
0.0033 |
| 206 |
ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC |
5 |
0.0033 |
| 207 |
PARTIAL SEIZURES |
17 |
0.0032 |
| 208 |
FEBRILE NEUTROPENIA |
215 |
0.0032 |
| 209 |
BLOOD ELECTROLYTES ABNORMAL |
4 |
0.0032 |
| 210 |
MYELITIS |
5 |
0.0032 |
| 211 |
CHOLESTASIS |
62 |
0.0032 |
| 212 |
VENOOCCLUSIVE DISEASE |
8 |
0.0032 |
| 213 |
COMPLICATIONS OF TRANSPLANTED KIDNEY |
7 |
0.0031 |
| 214 |
DRUG RESISTANCE |
79 |
0.0031 |
| 215 |
READING DISORDER |
7 |
0.0031 |
| 216 |
INTERCEPTED PRODUCT PRESCRIBING ERROR |
4 |
0.0030 |
| 217 |
BK VIRUS INFECTION |
10 |
0.0030 |
| 218 |
LEUKAEMIA RECURRENT |
5 |
0.0030 |
| 219 |
SARCOIDOSIS |
14 |
0.0029 |
| 220 |
KIDNEY TRANSPLANT REJECTION |
14 |
0.0029 |
| 221 |
VARICELLA ZOSTER VIRUS INFECTION |
6 |
0.0029 |
| 222 |
ACUTE MYELOID LEUKAEMIA |
45 |
0.0029 |
| 223 |
SCHIZOPHRENIA |
35 |
0.0029 |
| 224 |
PSEUDOMONAL SEPSIS |
5 |
0.0029 |
| 225 |
BREAST DISCHARGE |
5 |
0.0029 |
| 226 |
FANCONI SYNDROME ACQUIRED |
5 |
0.0028 |
| 227 |
CULTURE URINE POSITIVE |
4 |
0.0028 |
| 228 |
NASAL POLYPS |
14 |
0.0028 |
| 229 |
RHINOVIRUS INFECTION |
11 |
0.0028 |
| 230 |
GLOMERULAR FILTRATION RATE ABNORMAL |
4 |
0.0028 |
| 231 |
URINARY TRACT INFECTION BACTERIAL |
7 |
0.0028 |
| 232 |
RENAL TUBULAR ACIDOSIS |
6 |
0.0027 |
| 233 |
TRANSPLANT REJECTION |
22 |
0.0027 |
| 234 |
ENDOMETRIAL CANCER |
6 |
0.0027 |
| 235 |
RETROPERITONEAL HAEMATOMA |
6 |
0.0027 |
| 236 |
COVID-19 PNEUMONIA |
32 |
0.0027 |
| 237 |
DRUG ERUPTION |
48 |
0.0027 |
| 238 |
CHOLESTATIC LIVER INJURY |
6 |
0.0027 |
| 239 |
DUODENAL ULCER |
19 |
0.0027 |
| 240 |
PLASMACYTOMA |
5 |
0.0027 |
| 241 |
PULMONARY ALVEOLAR HAEMORRHAGE |
15 |
0.0027 |
| 242 |
SERUM FERRITIN INCREASED |
14 |
0.0027 |
| 243 |
HYPERVOLAEMIA |
13 |
0.0026 |
| 244 |
PROTEIN TOTAL INCREASED |
7 |
0.0026 |
| 245 |
ACUTE GRAFT VERSUS HOST DISEASE |
12 |
0.0026 |
| 246 |
SEPTIC SHOCK |
114 |
0.0026 |
| 247 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
67 |
0.0026 |
| 248 |
ABSCESS LIMB |
11 |
0.0026 |
| 249 |
PATHOGEN RESISTANCE |
23 |
0.0025 |
| 250 |
RESPIRATORY FAILURE |
184 |
0.0025 |
| 251 |
DRUG LEVEL INCREASED |
41 |
0.0025 |
| 252 |
OESOPHAGITIS |
27 |
0.0025 |
| 253 |
HAEMOLYSIS |
19 |
0.0025 |
| 254 |
CLOSTRIDIUM DIFFICILE COLITIS |
26 |
0.0024 |
| 255 |
HYPOGAMMAGLOBULINAEMIA |
16 |
0.0024 |
| 256 |
ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS |
6 |
0.0024 |
| 257 |
VASCULAR DEVICE INFECTION |
11 |
0.0024 |
| 258 |
LYME DISEASE |
8 |
0.0024 |
| 259 |
HISTIOCYTOSIS HAEMATOPHAGIC |
7 |
0.0024 |
| 260 |
B-CELL LYMPHOMA |
8 |
0.0024 |
| 261 |
SHOCK HAEMORRHAGIC |
19 |
0.0023 |
| 262 |
PHYSICAL DECONDITIONING |
6 |
0.0023 |
| 263 |
PERICARDIAL HAEMORRHAGE |
5 |
0.0023 |
| 264 |
INFECTION SUSCEPTIBILITY INCREASED |
5 |
0.0023 |
| 265 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
40 |
0.0023 |
| 266 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
6 |
0.0023 |
| 267 |
LIVER TRANSPLANT REJECTION |
4 |
0.0022 |
| 268 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
63 |
0.0022 |
| 269 |
PSEUDOMONAS INFECTION |
19 |
0.0022 |
| 270 |
BLOOD HIV RNA INCREASED |
4 |
0.0022 |
| 271 |
HEPATIC ENZYME ABNORMAL |
11 |
0.0022 |
| 272 |
DISSEMINATED INTRAVASCULAR COAGULATION |
31 |
0.0022 |
| 273 |
PNEUMONIA VIRAL |
7 |
0.0022 |
| 274 |
ACUTE RESPIRATORY FAILURE |
42 |
0.0022 |
| 275 |
HAEMOLYTIC URAEMIC SYNDROME |
5 |
0.0022 |
| 276 |
PLASMA CELL MYELOMA RECURRENT |
7 |
0.0022 |
| 277 |
THROMBOCYTOPENIA |
239 |
0.0021 |
| 278 |
CANDIDA INFECTION |
36 |
0.0021 |
| 279 |
FAILURE TO THRIVE |
11 |
0.0021 |
| 280 |
HEPATOTOXICITY |
47 |
0.0021 |
| 281 |
BONE MARROW TRANSPLANT |
4 |
0.0021 |
| 282 |
LUNG NEOPLASM |
9 |
0.0021 |
| 283 |
APLASTIC ANAEMIA |
11 |
0.0021 |
| 284 |
RETINAL VEIN OCCLUSION |
6 |
0.0021 |
| 285 |
AUTOIMMUNE HAEMOLYTIC ANAEMIA |
7 |
0.0020 |
| 286 |
RENAL TUBULAR NECROSIS |
20 |
0.0020 |
| 287 |
VENOOCCLUSIVE LIVER DISEASE |
10 |
0.0020 |
| 288 |
BLOOD IMMUNOGLOBULIN G DECREASED |
5 |
0.0020 |
| 289 |
EMPYEMA |
4 |
0.0020 |
| 290 |
ATYPICAL PNEUMONIA |
6 |
0.0020 |
| 291 |
STEM CELL TRANSPLANT |
5 |
0.0020 |
| 292 |
BLOOD PRESSURE DIASTOLIC ABNORMAL |
5 |
0.0020 |
| 293 |
MENINGITIS |
13 |
0.0019 |
| 294 |
DIASTOLIC DYSFUNCTION |
6 |
0.0019 |
| 295 |
CHRONIC GRAFT VERSUS HOST DISEASE |
7 |
0.0019 |
| 296 |
IMMUNOSUPPRESSION |
17 |
0.0019 |
| 297 |
COLITIS |
73 |
0.0019 |
| 298 |
HAEMOLYTIC ANAEMIA |
17 |
0.0019 |
| 299 |
GASTROINTESTINAL STROMAL TUMOUR |
5 |
0.0019 |
| 300 |
CARDIAC DYSFUNCTION |
7 |
0.0019 |
| 301 |
BONE MARROW FAILURE |
38 |
0.0019 |
| 302 |
HYPERPHOSPHATAEMIA |
4 |
0.0019 |
| 303 |
NEUTROPENIA |
250 |
0.0018 |
| 304 |
SUBDURAL HAEMORRHAGE |
5 |
0.0018 |
| 305 |
DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT |
4 |
0.0018 |
| 306 |
LUNG INFILTRATION |
16 |
0.0018 |
| 307 |
BACTERIAL TEST POSITIVE |
4 |
0.0018 |
| 308 |
HEPATIC FUNCTION ABNORMAL |
66 |
0.0018 |
| 309 |
HYPERKALAEMIA |
62 |
0.0018 |
| 310 |
LYMPHOPENIA |
25 |
0.0018 |
| 311 |
PNEUMATOSIS INTESTINALIS |
5 |
0.0018 |
| 312 |
SKIN PAPILLOMA |
7 |
0.0017 |
| 313 |
BLOOD BILIRUBIN INCREASED |
47 |
0.0017 |
| 314 |
CYTOMEGALOVIRUS COLITIS |
4 |
0.0017 |
| 315 |
CYSTITIS HAEMORRHAGIC |
7 |
0.0017 |
| 316 |
BLOOD PRESSURE DIASTOLIC INCREASED |
8 |
0.0017 |
| 317 |
RENAL FUNCTION TEST ABNORMAL |
8 |
0.0017 |
| 318 |
GASTRITIS EROSIVE |
8 |
0.0017 |
| 319 |
ANHEDONIA |
45 |
0.0017 |
| 320 |
BILIRUBIN CONJUGATED INCREASED |
4 |
0.0017 |
| 321 |
ERYTHEMA NODOSUM |
6 |
0.0017 |
| 322 |
PAPULE |
12 |
0.0017 |
| 323 |
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY |
14 |
0.0017 |
| 324 |
LUNG TRANSPLANT |
6 |
0.0017 |
| 325 |
HERPES SIMPLEX |
11 |
0.0017 |
| 326 |
RECALLED PRODUCT ADMINISTERED |
16 |
0.0017 |
| 327 |
ODYNOPHAGIA |
10 |
0.0017 |
| 328 |
ACUTE KIDNEY INJURY |
256 |
0.0017 |
| 329 |
NEUTROPHIL COUNT DECREASED |
68 |
0.0017 |
| 330 |
STEVENS-JOHNSON SYNDROME |
37 |
0.0017 |
| 331 |
DIABETES INSIPIDUS |
4 |
0.0017 |
| 332 |
HYPERCAPNIA |
5 |
0.0017 |
| 333 |
BONE MARROW DISORDER |
5 |
0.0017 |
| 334 |
OSTEOPENIA |
25 |
0.0016 |
| 335 |
CUTANEOUS VASCULITIS |
6 |
0.0016 |
| 336 |
HAEMATOLOGICAL INFECTION |
4 |
0.0016 |
| 337 |
PORTAL HYPERTENSION |
5 |
0.0016 |
| 338 |
BLOOD PRESSURE SYSTOLIC ABNORMAL |
4 |
0.0016 |
| 339 |
CHOLELITHIASIS |
53 |
0.0016 |
| 340 |
STAPHYLOCOCCAL INFECTION |
53 |
0.0016 |
| 341 |
HYPERPARATHYROIDISM SECONDARY |
4 |
0.0016 |
| 342 |
TUMOUR LYSIS SYNDROME |
14 |
0.0016 |
| 343 |
DYSLIPIDAEMIA |
8 |
0.0016 |
| 344 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
6 |
0.0016 |
| 345 |
ENTEROCOLITIS |
9 |
0.0016 |
| 346 |
IRON DEFICIENCY |
7 |
0.0016 |
| 347 |
ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT |
4 |
0.0015 |
| 348 |
RALES |
9 |
0.0015 |
| 349 |
LIVER ABSCESS |
5 |
0.0015 |
| 350 |
DRUG-INDUCED LIVER INJURY |
48 |
0.0015 |
| 351 |
HYPERLIPIDAEMIA |
18 |
0.0015 |
| 352 |
HYPOXIA |
53 |
0.0015 |
| 353 |
CARDIAC MURMUR |
13 |
0.0015 |
| 354 |
HYPOPHOSPHATAEMIA |
11 |
0.0015 |
| 355 |
ANAL ABSCESS |
8 |
0.0015 |
| 356 |
END STAGE RENAL DISEASE |
27 |
0.0015 |
| 357 |
SEPSIS |
165 |
0.0015 |
| 358 |
CHRONIC LYMPHOCYTIC LEUKAEMIA |
7 |
0.0015 |
| 359 |
CHOLANGITIS |
9 |
0.0015 |
| 360 |
HYPERTHERMIA |
11 |
0.0014 |
| 361 |
NECROSIS |
8 |
0.0014 |
| 362 |
PULMONARY TOXICITY |
10 |
0.0014 |
| 363 |
ESCHERICHIA URINARY TRACT INFECTION |
6 |
0.0014 |
| 364 |
ISCHAEMIC STROKE |
25 |
0.0014 |
| 365 |
PNEUMONITIS |
38 |
0.0014 |
| 366 |
RENAL TRANSPLANT |
5 |
0.0014 |
| 367 |
LEUKOCYTOSIS |
25 |
0.0014 |
| 368 |
LIVER TRANSPLANT |
5 |
0.0014 |
| 369 |
RASH PUSTULAR |
10 |
0.0014 |
| 370 |
AMYLASE INCREASED |
5 |
0.0014 |
| 371 |
PLATELET COUNT DECREASED |
144 |
0.0013 |
| 372 |
SKIN NECROSIS |
7 |
0.0013 |
| 373 |
SKIN MASS |
9 |
0.0013 |
| 374 |
NEPHROPATHY TOXIC |
15 |
0.0013 |
| 375 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
73 |
0.0013 |
| 376 |
SUSPECTED OFF LABEL USE |
6 |
0.0013 |
| 377 |
HIV INFECTION |
4 |
0.0013 |
| 378 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
21 |
0.0013 |
| 379 |
PARANASAL SINUS DISCOMFORT |
5 |
0.0013 |
| 380 |
ECONOMIC PROBLEM |
20 |
0.0013 |
| 381 |
EOSINOPHILIA |
23 |
0.0013 |
| 382 |
DISEASE COMPLICATION |
6 |
0.0013 |
| 383 |
IMMUNE THROMBOCYTOPENIA |
6 |
0.0013 |
| 384 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
29 |
0.0013 |
| 385 |
INTERSTITIAL LUNG DISEASE |
63 |
0.0013 |
| 386 |
OESOPHAGEAL ULCER |
5 |
0.0013 |
| 387 |
LEUKOPENIA |
65 |
0.0013 |
| 388 |
NEPHROGENIC ANAEMIA |
6 |
0.0013 |
| 389 |
TOXIC SKIN ERUPTION |
13 |
0.0013 |
| 390 |
DIARRHOEA HAEMORRHAGIC |
12 |
0.0013 |
| 391 |
FAECALOMA |
7 |
0.0013 |
| 392 |
HYPOCALCAEMIA |
24 |
0.0013 |
| 393 |
VIRAL UPPER RESPIRATORY TRACT INFECTION |
6 |
0.0013 |
| 394 |
SHOCK |
29 |
0.0013 |
| 395 |
RED BLOOD CELL COUNT DECREASED |
36 |
0.0013 |
| 396 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
12 |
0.0013 |
| 397 |
ALTERED STATE OF CONSCIOUSNESS |
27 |
0.0012 |
| 398 |
INTERNATIONAL NORMALISED RATIO DECREASED |
5 |
0.0012 |
| 399 |
HEPATITIS ACUTE |
8 |
0.0012 |
| 400 |
INCORRECT DOSAGE ADMINISTERED |
6 |
0.0012 |
| 401 |
ARTHRITIS BACTERIAL |
5 |
0.0012 |
| 402 |
CEREBRAL DISORDER |
9 |
0.0012 |
| 403 |
STAPHYLOCOCCAL SEPSIS |
6 |
0.0012 |
| 404 |
METABOLIC DISORDER |
7 |
0.0012 |
| 405 |
ELECTROLYTE IMBALANCE |
14 |
0.0012 |
| 406 |
HYDRONEPHROSIS |
9 |
0.0012 |
| 407 |
HEPATIC FAILURE |
36 |
0.0012 |
| 408 |
FULL BLOOD COUNT DECREASED |
24 |
0.0012 |
| 409 |
DRUG LEVEL DECREASED |
12 |
0.0012 |
| 410 |
PLASMA CELL MYELOMA |
46 |
0.0012 |
| 411 |
ENDOCARDITIS |
6 |
0.0012 |
| 412 |
PLEURAL EFFUSION |
71 |
0.0012 |
| 413 |
GASTROENTERITIS |
17 |
0.0012 |
| 414 |
APHTHOUS ULCER |
9 |
0.0012 |
| 415 |
AUTOIMMUNE HEPATITIS |
8 |
0.0011 |
| 416 |
PULMONARY FUNCTION TEST DECREASED |
5 |
0.0011 |
| 417 |
DEPRESSIVE SYMPTOM |
4 |
0.0011 |
| 418 |
HYPOPHAGIA |
29 |
0.0011 |
| 419 |
HEPATOCELLULAR INJURY |
16 |
0.0011 |
| 420 |
MYELODYSPLASTIC SYNDROME |
16 |
0.0011 |
| 421 |
SKIN LESION |
30 |
0.0011 |
| 422 |
MOUTH ULCERATION |
23 |
0.0011 |
| 423 |
ALANINE AMINOTRANSFERASE INCREASED |
67 |
0.0011 |
| 424 |
ASCITES |
32 |
0.0011 |
| 425 |
HAEMOGLOBIN ABNORMAL |
7 |
0.0011 |
| 426 |
BLOOD PRESSURE DIASTOLIC DECREASED |
8 |
0.0011 |
| 427 |
TRANSAMINASES INCREASED |
24 |
0.0011 |
| 428 |
JAUNDICE |
29 |
0.0011 |
| 429 |
LYMPHOCYTE COUNT DECREASED |
19 |
0.0011 |
| 430 |
BACTERIAL INFECTION |
20 |
0.0011 |
| 431 |
PYREXIA |
367 |
0.0011 |
| 432 |
LIVER INJURY |
26 |
0.0011 |
| 433 |
CATHETER SITE INFECTION |
4 |
0.0011 |
| 434 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
26 |
0.0010 |
| 435 |
PYELONEPHRITIS |
9 |
0.0010 |
| 436 |
LIVER DISORDER |
46 |
0.0010 |
| 437 |
HYPOALBUMINAEMIA |
8 |
0.0010 |
| 438 |
HYPOVOLAEMIA |
6 |
0.0010 |
| 439 |
EPIGASTRIC DISCOMFORT |
4 |
0.0010 |
| 440 |
PANCREATITIS ACUTE |
23 |
0.0010 |
| 441 |
ENCEPHALITIS |
7 |
0.0010 |
| 442 |
PNEUMONIA |
326 |
0.0010 |
| 443 |
RENAL FAILURE |
133 |
0.0010 |
| 444 |
COVID-19 |
175 |
0.0010 |
| 445 |
CANDIDIASIS |
4 |
0.0010 |
| 446 |
HEPATITIS CHOLESTATIC |
6 |
0.0010 |
| 447 |
PERICARDIAL EFFUSION |
23 |
0.0010 |
| 448 |
RENAL IMPAIRMENT |
83 |
0.0010 |
| 449 |
DERMATITIS ACNEIFORM |
6 |
0.0010 |
| 450 |
DEVICE RELATED INFECTION |
15 |
0.0010 |
| 451 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
10 |
0.0010 |
| 452 |
CELLULITIS |
48 |
0.0010 |
| 453 |
BLOOD LACTIC ACID INCREASED |
5 |
0.0009 |
| 454 |
IMMUNODEFICIENCY |
14 |
0.0009 |
| 455 |
ANAEMIA |
179 |
0.0009 |
| 456 |
VIROLOGIC FAILURE |
5 |
0.0009 |
| 457 |
GINGIVITIS |
5 |
0.0009 |
| 458 |
BLOOD MAGNESIUM DECREASED |
8 |
0.0009 |
| 459 |
STRESS FRACTURE |
5 |
0.0009 |
| 460 |
MYOPATHY |
8 |
0.0009 |
| 461 |
ASPARTATE AMINOTRANSFERASE INCREASED |
49 |
0.0009 |
| 462 |
DRUG INTERACTION |
146 |
0.0009 |
| 463 |
MUCOSAL INFLAMMATION |
24 |
0.0009 |
| 464 |
HYPOKALAEMIA |
42 |
0.0009 |
| 465 |
ADRENAL INSUFFICIENCY |
11 |
0.0009 |
| 466 |
PURPURA |
8 |
0.0009 |
| 467 |
STREPTOCOCCAL INFECTION |
5 |
0.0009 |
| 468 |
LUNG DISORDER |
44 |
0.0009 |
| 469 |
MALNUTRITION |
10 |
0.0009 |
| 470 |
MYOSITIS |
8 |
0.0009 |
| 471 |
ANAL INCONTINENCE |
8 |
0.0009 |
| 472 |
BLOOD CREATININE INCREASED |
58 |
0.0009 |
| 473 |
WHITE BLOOD CELL COUNT DECREASED |
96 |
0.0009 |
| 474 |
REBOUND EFFECT |
10 |
0.0009 |
| 475 |
DISEASE RECURRENCE |
42 |
0.0009 |
| 476 |
BLOOD ALBUMIN DECREASED |
7 |
0.0009 |
| 477 |
TREATMENT FAILURE |
73 |
0.0009 |
| 478 |
UROSEPSIS |
8 |
0.0009 |
| 479 |
BLOOD URIC ACID INCREASED |
5 |
0.0009 |
| 480 |
HYPERTRANSAMINASAEMIA |
6 |
0.0009 |
| 481 |
STRESS CARDIOMYOPATHY |
5 |
0.0009 |
| 482 |
CONDITION AGGRAVATED |
261 |
0.0009 |
| 483 |
ERYTHEMA MULTIFORME |
8 |
0.0009 |
| 484 |
NEUROTOXICITY |
15 |
0.0009 |
| 485 |
HYPERTRIGLYCERIDAEMIA |
5 |
0.0009 |
| 486 |
FULL BLOOD COUNT ABNORMAL |
9 |
0.0009 |
| 487 |
HYPERGLYCAEMIA |
31 |
0.0008 |
| 488 |
OFF LABEL USE |
742 |
0.0008 |
| 489 |
SPINAL COMPRESSION FRACTURE |
7 |
0.0008 |
| 490 |
LYMPHOMA |
13 |
0.0008 |
| 491 |
FUNGAL INFECTION |
28 |
0.0008 |
| 492 |
LIVER FUNCTION TEST INCREASED |
18 |
0.0008 |
| 493 |
HEPATIC ENZYME INCREASED |
57 |
0.0008 |
| 494 |
HEPATITIS B |
5 |
0.0008 |
| 495 |
DERMATITIS BULLOUS |
6 |
0.0008 |
| 496 |
MENTAL STATUS CHANGES |
23 |
0.0008 |
| 497 |
DYSPNOEA EXERTIONAL |
31 |
0.0008 |
| 498 |
BLOOD PRESSURE SYSTOLIC INCREASED |
16 |
0.0008 |
| 499 |
MELAENA |
18 |
0.0008 |
| 500 |
HYPERCALCAEMIA |
10 |
0.0008 |
| 501 |
TACHYPNOEA |
11 |
0.0008 |
| 502 |
HYPERNATRAEMIA |
4 |
0.0008 |
| 503 |
CENTRAL NERVOUS SYSTEM LESION |
11 |
0.0008 |
| 504 |
HYPERAMMONAEMIA |
4 |
0.0008 |
| 505 |
INFUSION SITE SWELLING |
5 |
0.0008 |
| 506 |
TASTE DISORDER |
16 |
0.0008 |
| 507 |
DISEASE PROGRESSION |
93 |
0.0008 |
| 508 |
GENERALISED TONIC-CLONIC SEIZURE |
13 |
0.0008 |
| 509 |
MYOCARDITIS |
9 |
0.0008 |
| 510 |
WHITE BLOOD CELL COUNT ABNORMAL |
5 |
0.0008 |
| 511 |
HEPATITIS |
20 |
0.0008 |
| 512 |
NEUTROPHIL COUNT INCREASED |
8 |
0.0008 |
| 513 |
CLOSTRIDIUM DIFFICILE INFECTION |
17 |
0.0008 |
| 514 |
SPLENOMEGALY |
9 |
0.0008 |
| 515 |
PETECHIAE |
8 |
0.0008 |
| 516 |
TRANSFUSION |
8 |
0.0008 |
| 517 |
ORAL CANDIDIASIS |
10 |
0.0008 |
| 518 |
DYSGRAPHIA |
5 |
0.0008 |
| 519 |
CORONAVIRUS INFECTION |
5 |
0.0008 |
| 520 |
MULTI-ORGAN FAILURE |
13 |
0.0008 |
| 521 |
PRESCRIBED UNDERDOSE |
15 |
0.0008 |
| 522 |
CARDIAC FAILURE ACUTE |
5 |
0.0007 |
| 523 |
LEFT VENTRICULAR DYSFUNCTION |
5 |
0.0007 |
| 524 |
QUALITY OF LIFE DECREASED |
10 |
0.0007 |
| 525 |
LOCALISED INFECTION |
18 |
0.0007 |
| 526 |
RHINITIS |
6 |
0.0007 |
| 527 |
C-REACTIVE PROTEIN INCREASED |
27 |
0.0007 |
| 528 |
LEUKAEMIA |
7 |
0.0007 |
| 529 |
DECUBITUS ULCER |
6 |
0.0007 |
| 530 |
HAEMATOMA |
19 |
0.0007 |
| 531 |
GLOMERULAR FILTRATION RATE DECREASED |
9 |
0.0007 |
| 532 |
MULTIPLE FRACTURES |
12 |
0.0007 |
| 533 |
NEPHROTIC SYNDROME |
5 |
0.0007 |
| 534 |
OSTEOPOROSIS |
30 |
0.0007 |
| 535 |
ECCHYMOSIS |
5 |
0.0007 |
| 536 |
BLOOD COUNT ABNORMAL |
11 |
0.0007 |
| 537 |
RESPIRATORY DISTRESS |
20 |
0.0007 |
| 538 |
GOUT |
13 |
0.0007 |
| 539 |
ACUTE CORONARY SYNDROME |
6 |
0.0007 |
| 540 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
8 |
0.0007 |
| 541 |
DIZZINESS POSTURAL |
7 |
0.0007 |
| 542 |
HAEMOGLOBIN DECREASED |
74 |
0.0007 |
| 543 |
HYPOMAGNESAEMIA |
10 |
0.0007 |
| 544 |
OSTEOMYELITIS |
13 |
0.0007 |
| 545 |
BLOOD UREA INCREASED |
12 |
0.0007 |
| 546 |
HAEMODIALYSIS |
6 |
0.0007 |
| 547 |
HERPES ZOSTER |
41 |
0.0007 |
| 548 |
HEPATOMEGALY |
7 |
0.0007 |
| 549 |
FACE OEDEMA |
12 |
0.0007 |
| 550 |
SEASONAL ALLERGY |
10 |
0.0007 |
| 551 |
DIALYSIS |
10 |
0.0007 |
| 552 |
GENERALISED ERYTHEMA |
4 |
0.0007 |
| 553 |
SKIN ULCER |
18 |
0.0007 |
| 554 |
OXYGEN SATURATION DECREASED |
39 |
0.0007 |
| 555 |
DEEP VEIN THROMBOSIS |
45 |
0.0007 |
| 556 |
FEEDING DISORDER |
14 |
0.0007 |
| 557 |
CHILLS |
80 |
0.0007 |
| 558 |
MOUTH HAEMORRHAGE |
5 |
0.0007 |
| 559 |
PNEUMONIA ASPIRATION |
17 |
0.0007 |
| 560 |
TREATMENT NONCOMPLIANCE |
37 |
0.0007 |
| 561 |
VENTRICULAR EXTRASYSTOLES |
7 |
0.0007 |
| 562 |
PULMONARY MASS |
10 |
0.0007 |
| 563 |
ACUTE HEPATIC FAILURE |
9 |
0.0007 |
| 564 |
CHRONIC KIDNEY DISEASE |
50 |
0.0007 |
| 565 |
HAEMODYNAMIC INSTABILITY |
5 |
0.0007 |
| 566 |
HEPATIC STEATOSIS |
12 |
0.0006 |
| 567 |
WOUND INFECTION |
7 |
0.0006 |
| 568 |
BONE DENSITY DECREASED |
20 |
0.0006 |
| 569 |
MUSCLE ATROPHY |
8 |
0.0006 |
| 570 |
PNEUMOTHORAX |
10 |
0.0006 |
| 571 |
SUBDURAL HAEMATOMA |
9 |
0.0006 |
| 572 |
SUPRAVENTRICULAR TACHYCARDIA |
6 |
0.0006 |
| 573 |
PULMONARY OEDEMA |
28 |
0.0006 |
| 574 |
INTESTINAL PERFORATION |
7 |
0.0006 |
| 575 |
OBSESSIVE-COMPULSIVE DISORDER |
5 |
0.0006 |
| 576 |
LIVER FUNCTION TEST ABNORMAL |
18 |
0.0006 |
| 577 |
MITRAL VALVE INCOMPETENCE |
7 |
0.0006 |
| 578 |
ATRIAL FIBRILLATION |
60 |
0.0006 |
| 579 |
RENAL FAILURE ACUTE |
26 |
0.0006 |
| 580 |
MYELOSUPPRESSION |
22 |
0.0006 |
| 581 |
PSYCHOTIC DISORDER |
18 |
0.0006 |
| 582 |
HAEMATOCRIT DECREASED |
12 |
0.0006 |
| 583 |
HAEMORRHAGE INTRACRANIAL |
9 |
0.0006 |
| 584 |
VIRAL INFECTION |
20 |
0.0006 |
| 585 |
SPINAL FRACTURE |
12 |
0.0006 |
| 586 |
BRAIN INJURY |
6 |
0.0006 |
| 587 |
PRODUCT USE IN UNAPPROVED INDICATION |
148 |
0.0006 |
| 588 |
APHASIA |
18 |
0.0006 |
| 589 |
COLITIS ISCHAEMIC |
4 |
0.0006 |
| 590 |
SKIN PLAQUE |
5 |
0.0006 |
| 591 |
INFECTION |
84 |
0.0006 |
| 592 |
RENAL DISORDER |
27 |
0.0006 |
| 593 |
LABORATORY TEST ABNORMAL |
17 |
0.0006 |
| 594 |
LARGE INTESTINE PERFORATION |
4 |
0.0006 |
| 595 |
METABOLIC ACIDOSIS |
18 |
0.0006 |
| 596 |
STOMATITIS |
34 |
0.0006 |
| 597 |
PARALYSIS |
8 |
0.0006 |
| 598 |
DECREASED ACTIVITY |
6 |
0.0006 |
| 599 |
LACTIC ACIDOSIS |
18 |
0.0006 |
| 600 |
BLOOD POTASSIUM INCREASED |
9 |
0.0006 |
| 601 |
ABDOMINAL PAIN LOWER |
14 |
0.0006 |
| 602 |
SKIN LACERATION |
6 |
0.0006 |
| 603 |
TACHYCARDIA |
49 |
0.0006 |
| 604 |
HYPONATRAEMIA |
31 |
0.0005 |
| 605 |
FAECES SOFT |
4 |
0.0005 |
| 606 |
DIARRHOEA |
355 |
0.0005 |
| 607 |
FLUID OVERLOAD |
8 |
0.0005 |
| 608 |
ASPIRATION |
6 |
0.0005 |
| 609 |
ACUTE MYOCARDIAL INFARCTION |
16 |
0.0005 |
| 610 |
DIPLOPIA |
14 |
0.0005 |
| 611 |
GASTROINTESTINAL HAEMORRHAGE |
45 |
0.0005 |
| 612 |
NEUROPATHY PERIPHERAL |
51 |
0.0005 |
| 613 |
DEAFNESS |
14 |
0.0005 |
| 614 |
PRESYNCOPE |
13 |
0.0005 |
| 615 |
FLANK PAIN |
5 |
0.0005 |
| 616 |
BONE LOSS |
8 |
0.0005 |
| 617 |
SQUAMOUS CELL CARCINOMA |
5 |
0.0005 |
| 618 |
BLOOD SODIUM DECREASED |
10 |
0.0005 |
| 619 |
FRACTURE |
10 |
0.0005 |
| 620 |
PULMONARY HYPERTENSION |
11 |
0.0005 |
| 621 |
SCAB |
6 |
0.0005 |
| 622 |
RASH |
229 |
0.0005 |
| 623 |
LIPASE INCREASED |
4 |
0.0005 |
| 624 |
DECREASED APPETITE |
121 |
0.0005 |
| 625 |
ATELECTASIS |
5 |
0.0005 |
| 626 |
ATRIOVENTRICULAR BLOCK |
4 |
0.0005 |
| 627 |
PRODUCT TASTE ABNORMAL |
7 |
0.0005 |
| 628 |
OEDEMA PERIPHERAL |
63 |
0.0005 |
| 629 |
VASCULITIS |
6 |
0.0005 |
| 630 |
EJECTION FRACTION DECREASED |
8 |
0.0005 |
| 631 |
INFUSION RELATED REACTION |
34 |
0.0005 |
| 632 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
15 |
0.0005 |
| 633 |
GASTROINTESTINAL INFLAMMATION |
4 |
0.0005 |
| 634 |
GENERAL PHYSICAL HEALTH DETERIORATION |
59 |
0.0005 |
| 635 |
BODY TEMPERATURE DECREASED |
5 |
0.0005 |
| 636 |
HOSPICE CARE |
5 |
0.0005 |
| 637 |
CHOLECYSTITIS |
6 |
0.0005 |
| 638 |
RESPIRATORY TRACT CONGESTION |
8 |
0.0005 |
| 639 |
INABILITY TO AFFORD MEDICATION |
5 |
0.0005 |
| 640 |
MYOCLONUS |
6 |
0.0005 |
| 641 |
PREMATURE DELIVERY |
8 |
0.0005 |
| 642 |
ATRIAL FLUTTER |
4 |
0.0005 |
| 643 |
ELECTROCARDIOGRAM QT PROLONGED |
18 |
0.0005 |
| 644 |
RESPIRATORY TRACT INFECTION |
13 |
0.0005 |
| 645 |
OEDEMA |
27 |
0.0005 |
| 646 |
WHITE BLOOD CELL COUNT INCREASED |
19 |
0.0005 |
| 647 |
GASTRITIS |
13 |
0.0005 |
| 648 |
SINUS TACHYCARDIA |
7 |
0.0005 |
| 649 |
INTENTIONAL PRODUCT USE ISSUE |
43 |
0.0005 |
| 650 |
BODY TEMPERATURE INCREASED |
10 |
0.0005 |
| 651 |
COUGH |
137 |
0.0005 |
| 652 |
CARDIOGENIC SHOCK |
7 |
0.0005 |
| 653 |
GENERALISED OEDEMA |
6 |
0.0005 |
| 654 |
PHARYNGITIS |
6 |
0.0005 |
| 655 |
PRODUCTIVE COUGH |
23 |
0.0005 |
| 656 |
EPISTAXIS |
36 |
0.0005 |
| 657 |
EYE DISCHARGE |
5 |
0.0005 |
| 658 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
19 |
0.0005 |
| 659 |
TENDERNESS |
5 |
0.0005 |
| 660 |
PRODUCT ODOUR ABNORMAL |
5 |
0.0005 |
| 661 |
DERMATITIS ALLERGIC |
6 |
0.0005 |
| 662 |
BRAIN OEDEMA |
6 |
0.0005 |
| 663 |
HYPOTENSION |
94 |
0.0005 |
| 664 |
HAEMATURIA |
16 |
0.0005 |
| 665 |
HAEMOPTYSIS |
13 |
0.0005 |
| 666 |
INFUSION SITE PAIN |
6 |
0.0005 |
| 667 |
BLOOD POTASSIUM DECREASED |
14 |
0.0005 |
| 668 |
ANURIA |
4 |
0.0005 |
| 669 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
10 |
0.0005 |
| 670 |
BLOOD PRESSURE FLUCTUATION |
11 |
0.0005 |
| 671 |
INSURANCE ISSUE |
7 |
0.0005 |
| 672 |
INTERNATIONAL NORMALISED RATIO INCREASED |
13 |
0.0005 |
| 673 |
TOOTH INFECTION |
6 |
0.0005 |
| 674 |
PANCREATITIS |
24 |
0.0005 |
| 675 |
CONSTIPATION |
99 |
0.0005 |
| 676 |
BLOOD PRESSURE ABNORMAL |
9 |
0.0005 |
| 677 |
LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR |
4 |
0.0005 |
| 678 |
CEREBRAL INFARCTION |
11 |
0.0004 |
| 679 |
THERAPY PARTIAL RESPONDER |
7 |
0.0004 |
| 680 |
SKIN INFECTION |
5 |
0.0004 |
| 681 |
STATUS EPILEPTICUS |
5 |
0.0004 |
| 682 |
UVEITIS |
6 |
0.0004 |
| 683 |
VOMITING |
207 |
0.0004 |
| 684 |
ABSCESS |
7 |
0.0004 |
| 685 |
MICTURITION URGENCY |
5 |
0.0004 |
| 686 |
CONTUSION |
42 |
0.0004 |
| 687 |
SENSORY DISTURBANCE |
7 |
0.0004 |
| 688 |
CARDIO-RESPIRATORY ARREST |
18 |
0.0004 |
| 689 |
HOSPITALISATION |
66 |
0.0004 |
| 690 |
HEPATIC ENCEPHALOPATHY |
4 |
0.0004 |
| 691 |
HEART RATE DECREASED |
15 |
0.0004 |
| 692 |
SPINAL PAIN |
5 |
0.0004 |
| 693 |
OSTEONECROSIS |
14 |
0.0004 |
| 694 |
DRUG INTOLERANCE |
41 |
0.0004 |
| 695 |
BLOOD IRON DECREASED |
5 |
0.0004 |
| 696 |
EMOTIONAL DISTRESS |
51 |
0.0004 |
| 697 |
DYSPNOEA |
238 |
0.0004 |
| 698 |
PRODUCT PRESCRIBING ERROR |
10 |
0.0004 |
| 699 |
EAR INFECTION |
11 |
0.0004 |
| 700 |
INFLAMMATORY BOWEL DISEASE |
4 |
0.0004 |
| 701 |
INFLAMMATION |
21 |
0.0004 |
| 702 |
CARDIOMEGALY |
5 |
0.0004 |
| 703 |
ILEUS |
5 |
0.0004 |
| 704 |
HAEMATOCHEZIA |
22 |
0.0004 |
| 705 |
CARDIAC FAILURE |
32 |
0.0004 |
| 706 |
NAUSEA |
313 |
0.0004 |
| 707 |
DIABETES MELLITUS INADEQUATE CONTROL |
7 |
0.0004 |
| 708 |
INFLUENZA |
44 |
0.0004 |
| 709 |
DEHYDRATION |
52 |
0.0004 |
| 710 |
RIB FRACTURE |
8 |
0.0004 |
| 711 |
HYPERTENSION |
82 |
0.0004 |
| 712 |
BLOOD PRESSURE INCREASED |
59 |
0.0004 |
| 713 |
RHABDOMYOLYSIS |
16 |
0.0004 |
| 714 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
20 |
0.0004 |
| 715 |
BRAIN FOG |
6 |
0.0004 |
| 716 |
FOLLICULITIS |
4 |
0.0004 |
| 717 |
GASTROINTESTINAL DISORDER |
34 |
0.0004 |
| 718 |
ANKYLOSING SPONDYLITIS |
5 |
0.0004 |
| 719 |
BRONCHITIS |
28 |
0.0004 |
| 720 |
THERAPY NON-RESPONDER |
17 |
0.0004 |
| 721 |
DYSSTASIA |
11 |
0.0004 |
| 722 |
RASH ERYTHEMATOUS |
18 |
0.0004 |
| 723 |
MIDDLE INSOMNIA |
7 |
0.0004 |
| 724 |
DELIRIUM |
13 |
0.0004 |
| 725 |
NEPHROLITHIASIS |
17 |
0.0004 |
| 726 |
SINUS CONGESTION |
5 |
0.0004 |
| 727 |
SKIN DISCOLOURATION |
17 |
0.0004 |
| 728 |
FAECES DISCOLOURED |
8 |
0.0004 |
| 729 |
BLOOD URINE PRESENT |
7 |
0.0004 |
| 730 |
PULMONARY EMBOLISM |
35 |
0.0004 |
| 731 |
BACK INJURY |
4 |
0.0004 |
| 732 |
TOXICITY TO VARIOUS AGENTS |
62 |
0.0004 |
| 733 |
BLOOD GLUCOSE FLUCTUATION |
4 |
0.0004 |
| 734 |
CARDIAC ARREST |
30 |
0.0004 |
| 735 |
VISUAL ACUITY REDUCED |
12 |
0.0004 |
| 736 |
DRY EYE |
18 |
0.0004 |
| 737 |
COAGULOPATHY |
6 |
0.0004 |
| 738 |
ASTHENIA |
135 |
0.0004 |
| 739 |
DYSPHAGIA |
34 |
0.0004 |
| 740 |
KIDNEY INFECTION |
7 |
0.0004 |
| 741 |
BLOOD TEST ABNORMAL |
5 |
0.0004 |
| 742 |
SKIN REACTION |
5 |
0.0004 |
| 743 |
EYE INFECTION |
4 |
0.0004 |
| 744 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
17 |
0.0004 |
| 745 |
FLUID RETENTION |
18 |
0.0004 |
| 746 |
PRODUCT AVAILABILITY ISSUE |
8 |
0.0004 |
| 747 |
THERAPY CESSATION |
18 |
0.0004 |
| 748 |
INTERNAL HAEMORRHAGE |
4 |
0.0003 |
| 749 |
PARANOIA |
6 |
0.0003 |
| 750 |
MATERNAL EXPOSURE DURING PREGNANCY |
31 |
0.0003 |
| 751 |
UPPER RESPIRATORY TRACT INFECTION |
16 |
0.0003 |
| 752 |
URINARY TRACT INFECTION |
59 |
0.0003 |
| 753 |
ORTHOSTATIC HYPOTENSION |
6 |
0.0003 |
| 754 |
FOETAL EXPOSURE DURING PREGNANCY |
28 |
0.0003 |
| 755 |
HEART RATE INCREASED |
34 |
0.0003 |
| 756 |
BONE PAIN |
20 |
0.0003 |
| 757 |
CONFUSIONAL STATE |
55 |
0.0003 |
| 758 |
CARDIOMYOPATHY |
5 |
0.0003 |
| 759 |
OROPHARYNGEAL PAIN |
31 |
0.0003 |
| 760 |
URINARY RETENTION |
11 |
0.0003 |
| 761 |
CHEST PAIN |
61 |
0.0003 |
| 762 |
EPILEPSY |
10 |
0.0003 |
| 763 |
SKIN CANCER |
7 |
0.0003 |
| 764 |
DYSPHONIA |
19 |
0.0003 |
| 765 |
DIVERTICULITIS |
9 |
0.0003 |
| 766 |
AMNESIA |
21 |
0.0003 |
| 767 |
ABDOMINAL PAIN |
75 |
0.0003 |
| 768 |
LUNG INFECTION |
5 |
0.0003 |
| 769 |
PRODUCT PRESCRIBING ISSUE |
7 |
0.0003 |
| 770 |
TUBULOINTERSTITIAL NEPHRITIS |
6 |
0.0003 |
| 771 |
FOOT FRACTURE |
6 |
0.0003 |
| 772 |
LUNG NEOPLASM MALIGNANT |
13 |
0.0003 |
| 773 |
LOWER LIMB FRACTURE |
6 |
0.0003 |
| 774 |
WEIGHT DECREASED |
87 |
0.0003 |
| 775 |
NIGHT SWEATS |
10 |
0.0003 |
| 776 |
ABDOMINAL DISCOMFORT |
52 |
0.0003 |
| 777 |
RHINORRHOEA |
20 |
0.0003 |
| 778 |
MUSCULAR WEAKNESS |
35 |
0.0003 |
| 779 |
ORAL HERPES |
6 |
0.0003 |
| 780 |
CEREBRAL HAEMORRHAGE |
11 |
0.0003 |
| 781 |
PERIPHERAL SWELLING |
47 |
0.0003 |
| 782 |
URINARY INCONTINENCE |
9 |
0.0003 |
| 783 |
RECTAL HAEMORRHAGE |
13 |
0.0003 |
| 784 |
DIABETES MELLITUS |
23 |
0.0003 |
| 785 |
RESTLESSNESS |
11 |
0.0003 |
| 786 |
GASTROOESOPHAGEAL REFLUX DISEASE |
24 |
0.0003 |
| 787 |
DRUG INEFFECTIVE |
392 |
0.0003 |
| 788 |
TYPE 2 DIABETES MELLITUS |
10 |
0.0003 |
| 789 |
GINGIVAL BLEEDING |
4 |
0.0003 |
| 790 |
ILLNESS |
30 |
0.0003 |
| 791 |
FATIGUE |
225 |
0.0003 |
| 792 |
HYPOGLYCAEMIA |
14 |
0.0003 |
| 793 |
POLLAKIURIA |
12 |
0.0003 |
| 794 |
PRODUCT USE ISSUE |
54 |
0.0003 |
| 795 |
HUNGER |
4 |
0.0003 |
| 796 |
HALLUCINATION, VISUAL |
6 |
0.0003 |
| 797 |
BLOOD TRIGLYCERIDES INCREASED |
5 |
0.0003 |
| 798 |
CYSTITIS |
9 |
0.0003 |
| 799 |
LYMPHADENOPATHY |
10 |
0.0003 |
| 800 |
GALLBLADDER DISORDER |
5 |
0.0003 |
| 801 |
DEATH |
241 |
0.0003 |
| 802 |
ABDOMINAL DISTENSION |
29 |
0.0003 |
| 803 |
DISORIENTATION |
11 |
0.0003 |
| 804 |
GASTROENTERITIS VIRAL |
5 |
0.0003 |
| 805 |
VISION BLURRED |
38 |
0.0003 |
| 806 |
VAGINAL HAEMORRHAGE |
12 |
0.0003 |
| 807 |
HYPERTHYROIDISM |
4 |
0.0003 |
| 808 |
HAEMATEMESIS |
7 |
0.0003 |
| 809 |
BONE DISORDER |
5 |
0.0003 |
| 810 |
BACK PAIN |
63 |
0.0003 |
| 811 |
BLOOD GLUCOSE ABNORMAL |
5 |
0.0003 |
| 812 |
SKIN DISORDER |
9 |
0.0003 |
| 813 |
WHEEZING |
16 |
0.0003 |
| 814 |
DYSGEUSIA |
20 |
0.0003 |
| 815 |
COLITIS ULCERATIVE |
12 |
0.0003 |
| 816 |
ORAL PAIN |
6 |
0.0003 |
| 817 |
THROAT IRRITATION |
12 |
0.0003 |
| 818 |
SWELLING |
25 |
0.0003 |
| 819 |
BLISTER |
15 |
0.0003 |
| 820 |
ANXIETY |
76 |
0.0003 |
| 821 |
THERAPY INTERRUPTED |
19 |
0.0003 |
| 822 |
DYSARTHRIA |
10 |
0.0003 |
| 823 |
CONTRAINDICATED PRODUCT ADMINISTERED |
8 |
0.0003 |
| 824 |
THERAPEUTIC RESPONSE DECREASED |
16 |
0.0003 |
| 825 |
ABDOMINAL PAIN UPPER |
54 |
0.0003 |
| 826 |
LETHARGY |
15 |
0.0003 |
| 827 |
DRY MOUTH |
21 |
0.0003 |
| 828 |
LIMB INJURY |
7 |
0.0003 |
| 829 |
HAEMORRHOIDS |
5 |
0.0003 |
| 830 |
PALPITATIONS |
30 |
0.0003 |
| 831 |
NASAL CONGESTION |
15 |
0.0003 |
| 832 |
CYANOSIS |
4 |
0.0003 |
| 833 |
CHEST DISCOMFORT |
26 |
0.0003 |
| 834 |
CATARACT |
15 |
0.0003 |
| 835 |
PRODUCT DOSE OMISSION ISSUE |
74 |
0.0003 |
| 836 |
SEIZURE |
29 |
0.0003 |
| 837 |
UPPER LIMB FRACTURE |
5 |
0.0003 |
| 838 |
HIP FRACTURE |
8 |
0.0002 |
| 839 |
PRODUCT PHYSICAL ISSUE |
5 |
0.0002 |
| 840 |
NEURALGIA |
6 |
0.0002 |
| 841 |
HYPERSOMNIA |
7 |
0.0002 |
| 842 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
7 |
0.0002 |
| 843 |
BALANCE DISORDER |
21 |
0.0002 |
| 844 |
OSTEONECROSIS OF JAW |
6 |
0.0002 |
| 845 |
TOOTH LOSS |
5 |
0.0002 |
| 846 |
AGEUSIA |
6 |
0.0002 |
| 847 |
RASH PRURITIC |
13 |
0.0002 |
| 848 |
GAIT DISTURBANCE |
45 |
0.0002 |
| 849 |
EATING DISORDER |
5 |
0.0002 |
| 850 |
MALIGNANT NEOPLASM PROGRESSION |
24 |
0.0002 |
| 851 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
4 |
0.0002 |
| 852 |
HEADACHE |
146 |
0.0002 |
| 853 |
ANAPHYLACTIC SHOCK |
6 |
0.0002 |
| 854 |
UNRESPONSIVE TO STIMULI |
6 |
0.0002 |
| 855 |
RASH MACULAR |
8 |
0.0002 |
| 856 |
PRURITUS |
87 |
0.0002 |
| 857 |
BRADYCARDIA |
12 |
0.0002 |
| 858 |
FEMUR FRACTURE |
7 |
0.0002 |
| 859 |
BLOOD PRESSURE DECREASED |
15 |
0.0002 |
| 860 |
EXPOSURE DURING PREGNANCY |
14 |
0.0002 |
| 861 |
TOOTH DISORDER |
5 |
0.0002 |
| 862 |
NERVOUS SYSTEM DISORDER |
7 |
0.0002 |
| 863 |
THROMBOSIS |
18 |
0.0002 |
| 864 |
TREMOR |
37 |
0.0002 |
| 865 |
CHROMATURIA |
5 |
0.0002 |
| 866 |
PAIN |
136 |
0.0002 |
| 867 |
HYPOTHYROIDISM |
7 |
0.0002 |
| 868 |
ERYTHEMA |
45 |
0.0002 |
| 869 |
INFLUENZA LIKE ILLNESS |
18 |
0.0002 |
| 870 |
JOINT SWELLING |
26 |
0.0002 |
| 871 |
SINUSITIS |
22 |
0.0002 |
| 872 |
BLOOD CHOLESTEROL INCREASED |
10 |
0.0002 |
| 873 |
INSOMNIA |
57 |
0.0002 |
| 874 |
BURNING SENSATION |
15 |
0.0002 |
| 875 |
EYE PAIN |
12 |
0.0002 |
| 876 |
HALLUCINATION |
16 |
0.0002 |
| 877 |
INTESTINAL OBSTRUCTION |
8 |
0.0002 |
| 878 |
PAIN IN JAW |
6 |
0.0002 |
| 879 |
ECZEMA |
11 |
0.0002 |
| 880 |
LIP SWELLING |
7 |
0.0002 |
| 881 |
WEIGHT INCREASED |
47 |
0.0002 |
| 882 |
ERUCTATION |
4 |
0.0002 |
| 883 |
ADVERSE EVENT |
19 |
0.0002 |
| 884 |
HYPERSENSITIVITY |
38 |
0.0002 |
| 885 |
MUSCLE SPASMS |
37 |
0.0002 |
| 886 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
36 |
0.0002 |
| 887 |
ANAPHYLACTIC REACTION |
11 |
0.0002 |
| 888 |
DIZZINESS |
99 |
0.0002 |
| 889 |
BLINDNESS |
8 |
0.0002 |
| 890 |
TINNITUS |
9 |
0.0002 |
| 891 |
MALAISE |
85 |
0.0002 |
| 892 |
PANIC ATTACK |
7 |
0.0002 |
| 893 |
ACCIDENTAL OVERDOSE |
7 |
0.0002 |
| 894 |
URTICARIA |
32 |
0.0002 |
| 895 |
DERMATITIS |
4 |
0.0002 |
| 896 |
SPEECH DISORDER |
10 |
0.0002 |
| 897 |
EYE SWELLING |
7 |
0.0002 |
| 898 |
IMPAIRED WORK ABILITY |
4 |
0.0002 |
| 899 |
CARDIAC FAILURE CONGESTIVE |
15 |
0.0002 |
| 900 |
THROAT TIGHTNESS |
5 |
0.0002 |
| 901 |
SWELLING FACE |
12 |
0.0002 |
| 902 |
PRODUCT DOSE OMISSION |
12 |
0.0002 |
| 903 |
FALL |
61 |
0.0002 |
| 904 |
PAIN IN EXTREMITY |
54 |
0.0002 |
| 905 |
DYSPEPSIA |
18 |
0.0002 |
| 906 |
NECK PAIN |
10 |
0.0002 |
| 907 |
WOUND |
5 |
0.0002 |
| 908 |
EYE PRURITUS |
6 |
0.0002 |
| 909 |
PRODUCT DOSE OMISSION IN ERROR |
5 |
0.0002 |
| 910 |
NASOPHARYNGITIS |
32 |
0.0002 |
| 911 |
UNEVALUABLE EVENT |
13 |
0.0002 |
| 912 |
COGNITIVE DISORDER |
8 |
0.0002 |
| 913 |
MYALGIA |
29 |
0.0002 |
| 914 |
SYNCOPE |
17 |
0.0002 |
| 915 |
RENAL INJURY |
5 |
0.0002 |
| 916 |
RESPIRATORY DISORDER |
5 |
0.0002 |
| 917 |
HYPOAESTHESIA |
25 |
0.0002 |
| 918 |
PREMATURE BABY |
5 |
0.0002 |
| 919 |
OSTEOARTHRITIS |
7 |
0.0002 |
| 920 |
VERTIGO |
10 |
0.0002 |
| 921 |
ARTHRALGIA |
67 |
0.0002 |
| 922 |
MENTAL DISORDER |
7 |
0.0002 |
| 923 |
SOMNOLENCE |
32 |
0.0002 |
| 924 |
LOSS OF CONSCIOUSNESS |
20 |
0.0002 |
| 925 |
MOVEMENT DISORDER |
5 |
0.0002 |
| 926 |
MUSCULOSKELETAL PAIN |
8 |
0.0002 |
| 927 |
JOINT STIFFNESS |
4 |
0.0002 |
| 928 |
NEOPLASM MALIGNANT |
10 |
0.0001 |
| 929 |
ABNORMAL DREAMS |
4 |
0.0001 |
| 930 |
FEELING COLD |
4 |
0.0001 |
| 931 |
DRY SKIN |
19 |
0.0001 |
| 932 |
SKIN EXFOLIATION |
12 |
0.0001 |
| 933 |
SLEEP DISORDER |
10 |
0.0001 |
| 934 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
10 |
0.0001 |
| 935 |
ARTHRITIS |
11 |
0.0001 |
| 936 |
HYPERHIDROSIS |
18 |
0.0001 |
| 937 |
UNDERDOSE |
10 |
0.0001 |
| 938 |
DYSURIA |
5 |
0.0001 |
| 939 |
ANGIOEDEMA |
6 |
0.0001 |
| 940 |
THERAPEUTIC RESPONSE UNEXPECTED |
6 |
0.0001 |
| 941 |
LOWER RESPIRATORY TRACT INFECTION |
6 |
0.0001 |
| 942 |
DEPRESSION |
30 |
0.0001 |
| 943 |
ILL-DEFINED DISORDER |
8 |
0.0001 |
| 944 |
DISCOMFORT |
8 |
0.0001 |
| 945 |
FEELING HOT |
8 |
0.0001 |
| 946 |
VISUAL IMPAIRMENT |
16 |
0.0001 |
| 947 |
ARRHYTHMIA |
6 |
0.0001 |
| 948 |
OCULAR HYPERAEMIA |
6 |
0.0001 |
| 949 |
COMA |
6 |
0.0001 |
| 950 |
CEREBROVASCULAR ACCIDENT |
21 |
0.0001 |
| 951 |
AGITATION |
9 |
0.0001 |
| 952 |
PRODUCT SUBSTITUTION ISSUE |
7 |
0.0001 |
| 953 |
PARAESTHESIA |
19 |
0.0001 |
| 954 |
ROAD TRAFFIC ACCIDENT |
5 |
0.0001 |
| 955 |
ACNE |
9 |
0.0001 |
| 956 |
GASTRIC DISORDER |
4 |
0.0001 |
| 957 |
MEMORY IMPAIRMENT |
16 |
0.0001 |
| 958 |
IRRITABILITY |
7 |
0.0001 |
| 959 |
NERVOUSNESS |
6 |
0.0001 |
| 960 |
ADVERSE DRUG REACTION |
10 |
0.0001 |
| 961 |
DISTURBANCE IN ATTENTION |
6 |
0.0001 |
| 962 |
CRYING |
4 |
0.0001 |
| 963 |
INCORRECT DOSE ADMINISTERED |
25 |
0.0001 |
| 964 |
MYOCARDIAL INFARCTION |
19 |
0.0001 |
| 965 |
ARTHROPATHY |
6 |
0.0001 |
| 966 |
CARDIAC DISORDER |
10 |
0.0001 |
| 967 |
HAEMORRHAGE |
11 |
0.0001 |
| 968 |
CONVULSION |
6 |
0.0001 |
| 969 |
SURGERY |
6 |
0.0001 |
| 970 |
ASTHMA |
11 |
0.0001 |
| 971 |
FEELING ABNORMAL |
23 |
0.0001 |
| 972 |
DERMATITIS ATOPIC |
5 |
0.0001 |
| 973 |
HYPOACUSIS |
4 |
0.0001 |
| 974 |
PRODUCT STORAGE ERROR |
8 |
0.0001 |
| 975 |
BLOOD GLUCOSE INCREASED |
17 |
0.0001 |
| 976 |
MEDICATION ERROR |
5 |
0.0001 |
| 977 |
NO ADVERSE EVENT |
16 |
0.0001 |
| 978 |
FLATULENCE |
5 |
0.0001 |
| 979 |
MOBILITY DECREASED |
6 |
0.0001 |
| 980 |
ALOPECIA |
14 |
0.0001 |
| 981 |
OVERDOSE |
15 |
0.0001 |
| 982 |
DRUG DOSE OMISSION |
11 |
0.0001 |
| 983 |
MIGRAINE |
6 |
0.0001 |
| 984 |
INJECTION SITE PRURITUS |
4 |
0.0001 |
| 985 |
FLUSHING |
6 |
0.0001 |
| 986 |
INTENTIONAL PRODUCT MISUSE |
5 |
0.0001 |
| 987 |
INJURY |
4 |
0.0001 |
| 988 |
SUICIDAL IDEATION |
5 |
0.0001 |
| 989 |
RHEUMATOID ARTHRITIS |
6 |
0.0001 |
| 990 |
INJECTION SITE HAEMORRHAGE |
4 |
0.0001 |
| 991 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
10 |
0.0000 |
| 992 |
INJECTION SITE ERYTHEMA |
6 |
0.0000 |
| 993 |
INJECTION SITE PAIN |
14 |
0.0000 |